Is it time to rethink your treatment strategy in calcified iliac arteries?

1835

This educational supplement is sponsored by Shockwave Medical. Explore the full Shockwave L6 series here.

In this supplement:

  • Michel Bosiers (University Hospital Bern, Bern, Switzerland) explains how the new Shockwave L6 can change the game in the treatment of calcified iliac disease.
  • Mark Portou (Royal Free Hospital, London, UK) shares a case of a patient who presented with chronic limb-threatening ischaemia (CLTI) and common iliac disease. See how the new Shockwave L6 enabled a ‘leave nothing behind’ strategy and resulted in resolution of the patient’s symptoms and complete wound healing. Click here to view corresponding video interview.
  • Stefano Fazzini (University of Rome Tor Vergata, Rome, Italy) presents a calcified external iliac artery case, where anatomical variation presents a challenge to attaining a good clinical outcome. See how the Shockwave L6 helped mitigate the complexities of this case. Click here to view corresponding video interview.
  • Ashish Patel (Guy’s and St Thomas’ NHS Foundation Trust and King’s College London, London, UK) outlines a case report demonstrating how the new Shockwave L6 catheter represents a “significant addition” to clinicians’ armamentarium for the endovascular treatment of aortoiliac occlusive disease. Click here to view corresponding video interview.

LEAVE A REPLY

Please enter your comment!
Please enter your name here